{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:32Z","timestamp":1787238032340,"version":"build-2736575974"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["RO1DK082971"],"award-info":[{"award-number":["RO1DK082971"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["RO1DK082971"],"award-info":[{"award-number":["RO1DK082971"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TR 1642\/1-1"],"award-info":[{"award-number":["TR 1642\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["18TPA34230025"],"award-info":[{"award-number":["18TPA34230025"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["K08HL111210"],"award-info":[{"award-number":["K08HL111210"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL142809"],"award-info":[{"award-number":["R01HL142809"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.phrs.2020.104664","type":"journal-article","created":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T11:38:55Z","timestamp":1579952335000},"page":"104664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["The role of hepcidin and iron homeostasis in atherosclerosis"],"prefix":"10.1016","volume":"153","author":[{"given":"Florian","family":"Wunderer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Traeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haakon H.","family":"Sigurslid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Meybohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5704","key":"10.1016\/j.phrs.2020.104664_bib0005","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.phrs.2020.104664_bib0010","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0015","first-page":"S6","article-title":"Overview of iron metabolism in health and disease","volume":"21","author":"Dev","year":"2017","journal-title":"Hemodial. Int."},{"issue":"8 Suppl","key":"10.1016\/j.phrs.2020.104664_bib0020","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7347","key":"10.1016\/j.phrs.2020.104664_bib0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.phrs.2020.104664_bib0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM197608122950707","article-title":"The pathogenesis of atherosclerosis (first of two parts)","volume":"295","author":"Ross","year":"1976","journal-title":"N. Engl. J. Med."},{"issue":"9859","key":"10.1016\/j.phrs.2020.104664_bib0035","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.phrs.2020.104664_bib0040","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM199711063371906","article-title":"Shattuck lecture\u2014cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities","volume":"337","author":"Braunwald","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.phrs.2020.104664_bib0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM197710202971608","article-title":"Cellular mechanisms for lipid deposition in atherosclerosis (first of two parts)","volume":"297","author":"Small","year":"1977","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. The road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcm.2008.11.004","article-title":"Monocyte-endothelial cell interactions in the development of atherosclerosis","volume":"18","author":"Mestas","year":"2008","journal-title":"Trends Cardiovasc. Med."},{"issue":"16","key":"10.1016\/j.phrs.2020.104664_bib0070","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0075","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.hlc.2013.03.001","article-title":"Pathophysiology of atherosclerosis plaque progression","volume":"22","author":"Sakakura","year":"2013","journal-title":"Heart Lung Circ."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1024\/0301-1526\/a000603","article-title":"German guideline on the diagnosis and treatment of peripheral artery disease\u2014a comprehensive update 2016","volume":"46","author":"Lawall","year":"2017","journal-title":"VASA Z. Gefasskrankh."},{"key":"10.1016\/j.phrs.2020.104664_bib0085","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease","volume":"2019","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2020.104664_bib0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis."},{"issue":"9493","key":"10.1016\/j.phrs.2020.104664_bib0095","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"9976","key":"10.1016\/j.phrs.2020.104664_bib0100","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jjcc.2017.02.004","article-title":"Current status of lipid management in acute coronary syndrome","volume":"70","author":"Fujisue","year":"2017","journal-title":"J. Cardiol."},{"issue":"12","key":"10.1016\/j.phrs.2020.104664_bib0110","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"10.1016\/j.phrs.2020.104664_bib0115","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0120","article-title":"Therapeutic approaches targeting inflammation in cardiovascular disorders","volume":"7","author":"Jones","year":"2018","journal-title":"Biology (Basel)"},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1084\/jem.180.3.969","article-title":"Iron regulates nitric oxide synthase activity by controlling nuclear transcription","volume":"180","author":"Weiss","year":"1994","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.phrs.2020.104664_bib0130","first-page":"3322","article-title":"Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice","volume":"119","author":"Wang","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"51","key":"10.1016\/j.phrs.2020.104664_bib0135","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1038\/sj.onc.1209936","article-title":"Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance","volume":"25","author":"Bubici","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00005-010-0095-9","article-title":"Iron and immunity: immunological consequences of iron deficiency and overload","volume":"58","author":"Cherayil","year":"2010","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"43","key":"10.1016\/j.phrs.2020.104664_bib0145","first-page":"26","article-title":"Hepcidin and iron homeostasis","volume":"9","author":"Ganz","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"2\u20133","key":"10.1016\/j.phrs.2020.104664_bib0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.phrs.2020.104664_bib0155","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"A urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0160","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","article-title":"A key regulator of iron metabolism and mediator of anemia of inflammation","volume":"102","author":"Hepcidin","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.phrs.2020.104664_bib0165","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nri3863","article-title":"Iron homeostasis in host defence and inflammation","volume":"15","author":"Ganz","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"15","key":"10.1016\/j.phrs.2020.104664_bib0170","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.151179498","article-title":"Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice","volume":"98","author":"Nicolas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.phrs.2020.104664_bib0175","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1073\/pnas.161296298","article-title":"Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease","volume":"98","author":"Fleming","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MOH.0000000000000236","article-title":"Hepcidin regulation in the anemia of inflammation","volume":"23","author":"Wang","year":"2016","journal-title":"Curr. Opin. Hematol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","article-title":"A red carpet for iron metabolism","volume":"168","author":"Muckenthaler","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0190","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1096\/fj.09-152561","article-title":"Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone","volume":"24","author":"Chung","year":"2010","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.phrs.2020.104664_bib0195","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1182\/blood-2010-05-286260","article-title":"Detection, evaluation, and management of iron-restricted erythropoiesis","volume":"116","author":"Goodnough","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0200","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.320","article-title":"Lack of the bone morphogenetic protein BMP6 induces massive iron overload","volume":"41","author":"Meynard","year":"2009","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0205","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2016-07-729822","article-title":"Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis","volume":"129","author":"Koch","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2020.104664_bib0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-nutr-071813-105646","article-title":"Bone morphogenetic proteins as regulators of iron metabolism","volume":"34","author":"Parrow","year":"2014","journal-title":"Annu. Rev. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0215","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrcardio.2015.156","article-title":"Targeting BMP signalling in cardiovascular disease and anaemia","volume":"13","author":"Morrell","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104664_bib0220","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3390\/nu5083034","article-title":"Out of balance\u2014systemic iron homeostasis in iron-related disorders","volume":"5","author":"Steinbicker","year":"2013","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.phrs.2020.104664_bib0225","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1182\/blood-2011-03-339952","article-title":"Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice","volume":"118","author":"Steinbicker","year":"2011","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.phrs.2020.104664_bib0230","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood-2013-02-480095","article-title":"The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6","volume":"123","author":"Mayeur","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nchembio.2007.54","article-title":"Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism","volume":"4","author":"Yu","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"18","key":"10.1016\/j.phrs.2020.104664_bib0240","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1182\/blood-2010-10-313064","article-title":"Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation","volume":"117","author":"Steinbicker","year":"2011","journal-title":"Blood"},{"issue":"8233","key":"10.1016\/j.phrs.2020.104664_bib0245","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(81)92463-6","article-title":"Iron and the sex difference in heart disease risk","volume":"1","author":"Sullivan","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0250","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0002-8703(89)90887-9","article-title":"The iron paradigm of ischemic heart disease","volume":"117","author":"Sullivan","year":"1989","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0255","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","article-title":"Menopause and risk of cardiovascular disease: the Framingham study","volume":"85","author":"Kannel","year":"1976","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.metabol.2004.10.012","article-title":"Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes","volume":"54","author":"Kraml","year":"2005","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0265","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.freeradbiomed.2006.11.014","article-title":"Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques","volume":"42","author":"Lapenna","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0270","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/10715760601091642","article-title":"Body iron is a contributor to oxidative damage of DNA","volume":"41","author":"Tuomainen","year":"2007","journal-title":"Free Radic. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0275","first-page":"95","article-title":"Association between serum iron and the severity of coronary artery disease","volume":"7","author":"Bagheri","year":"2013","journal-title":"Int. Cardiovasc. Res. J."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0280","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.CIR.86.3.803","article-title":"High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men","volume":"86","author":"Salonen","year":"1992","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.phrs.2020.104664_bib0285","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1161\/01.CIR.96.10.3300","article-title":"Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study","volume":"96","author":"Kiechl","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2020.104664_bib0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2261-9-34","article-title":"The association of biomarkers of iron status with peripheral arterial disease in US adults","volume":"9","author":"Menke","year":"2009","journal-title":"BMC Cardiovasc. Disord."},{"issue":"10","key":"10.1016\/j.phrs.2020.104664_bib0295","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1161\/ATVBAHA.112.253088","article-title":"Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men","volume":"32","author":"Sung","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0300","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.aje.a009669","article-title":"Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study","volume":"148","author":"Salonen","year":"1998","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.phrs.2020.104664_bib0305","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1537-2995.2002.00186.x","article-title":"A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events","volume":"42","author":"Meyers","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.phrs.2020.104664_bib0310","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1741-7015-10-54","article-title":"Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial","volume":"10","author":"Houschyar","year":"2012","journal-title":"BMC Med."},{"issue":"23","key":"10.1016\/j.phrs.2020.104664_bib0315","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/01.CIR.103.23.2799","article-title":"Iron chelation improves endothelial function in patients with coronary artery disease","volume":"103","author":"Duffy","year":"2001","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.phrs.2020.104664_bib0320","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/ATVBAHA.117.309757","article-title":"The effect of Iron status on risk of coronary artery disease: a mendelian randomization study-brief report","volume":"37","author":"Gill","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0325","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.297.6.603","article-title":"Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial","volume":"297","author":"Zacharski","year":"2007","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.phrs.2020.104664_bib0330","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3390\/nu5072384","article-title":"Iron: protector or risk factor for cardiovascular disease? Still controversial","volume":"5","author":"Munoz-Bravo","year":"2013","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0335","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3961\/jpmph.2012.45.3.196","article-title":"Associations of serum ferritin and transferrin % saturation with all-cause, cancer, and cardiovascular disease mortality: Third National Health and Nutrition Examination Survey follow-up study","volume":"45","author":"Kim","year":"2012","journal-title":"J. Prev. Med. Publ. Health"},{"key":"10.1016\/j.phrs.2020.104664_bib0340","article-title":"Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction","author":"Vinchi","year":"2019","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.phrs.2020.104664_bib0345","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/01.CIR.99.9.1222","article-title":"Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice","volume":"99","author":"Lee","year":"1999","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0350","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1258\/ebm.2009.009229","article-title":"The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice","volume":"235","author":"Zhang","year":"2010","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"10","key":"10.1016\/j.phrs.2020.104664_bib0355","first-page":"28518","article-title":"Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages","volume":"29","author":"Hu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.phrs.2020.104664_bib0360","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI7664","article-title":"Iron overload diminishes atherosclerosis in apoE-deficient mice","volume":"107","author":"Kirk","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0365","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.celrep.2013.11.009","article-title":"Testing the iron hypothesis in a mouse model of atherosclerosis","volume":"5","author":"Kautz","year":"2013","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0370","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCULATIONAHA.104.496075","article-title":"Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study","volume":"112","author":"Ellervik","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0375","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCGENETICS.109.906230","article-title":"Do hemochromatosis mutations protect against iron-mediated atherogenesis?","volume":"2","author":"Sullivan","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0380","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jama.1994.03520030073031","article-title":"Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease","volume":"272","author":"Miller","year":"1994","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0385","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/ATVBAHA.110.214858","article-title":"Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations","volume":"31","author":"Valenti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0390","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2362.2001.00830.x","article-title":"Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart disease","volume":"31","author":"Sullivan","year":"2001","journal-title":"Eur. J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0395","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/ATVBAHA.112.300173","article-title":"Phenotypic polarization of macrophages in atherosclerosis","volume":"33","author":"Leitinger","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104664_bib0400","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0405","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","article-title":"Distribution of macrophage polarization markers in human atherosclerosis","volume":"225","author":"Stoger","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2020.104664_bib0410","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bcmd.2016.07.006","article-title":"Inflammation-induced up-regulation of hepcidin and down-regulation of ferroportin transcription are dependent on macrophage polarization","volume":"61","author":"Agoro","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"issue":"11","key":"10.1016\/j.phrs.2020.104664_bib0415","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3324\/haematol.2010.023879","article-title":"Polarization dictates iron handling by inflammatory and alternatively activated macrophages","volume":"95","author":"Corna","year":"2010","journal-title":"Haematologica"},{"issue":"Supplementum 1","key":"10.1016\/j.phrs.2020.104664_bib0420","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.33549\/physiolres.933589","article-title":"The role of iron in the pathogenesis of atherosclerosis","volume":"66","author":"Kraml","year":"2017","journal-title":"Physiol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0425","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.phrs.2020.104664_bib0430","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/ATVBAHA.110.221127","article-title":"Monocyte and macrophage dynamics during atherogenesis","volume":"31","author":"Ley","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0435","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0440","first-page":"74","article-title":"Differing association of macrophage subsets with atherosclerotic plaque stability","volume":"32","author":"Medbury","year":"2013","journal-title":"Int. Angiol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0445","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCRESAHA.111.253377","article-title":"NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis","volume":"110","author":"Hanna","year":"2012","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0450","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/eji.200939889","article-title":"Differential regulation of iron homeostasis during human macrophage polarized activation","volume":"40","author":"Recalcati","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0455","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/11072","article-title":"Haem oxygenase-1 prevents cell death by regulating cellular iron","volume":"1","author":"Ferris","year":"1999","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0460","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.it.2011.03.007","article-title":"Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype","volume":"32","author":"Cairo","year":"2011","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","article-title":"Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo","volume":"17","author":"Jetten","year":"2014","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0470","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104664_bib0475","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.4049\/jimmunol.1200662","article-title":"Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction","volume":"189","author":"Zizzo","year":"2012","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2020.104664_bib0480","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.ATV.0000184783.04864.9f","article-title":"Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency","volume":"25","author":"Tabas","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0485","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2011.10.852","article-title":"Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques","volume":"59","author":"Finn","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0490","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/ars.2009.2792","article-title":"Hemoglobin and heme scavenger receptors","volume":"12","author":"Nielsen","year":"2010","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0495","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1161\/ATVBAHA.117.309045","article-title":"Linking hemorrhage, angiogenesis, macrophages, and iron metabolism in atherosclerotic vascular diseases","volume":"37","author":"Guo","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2020.104664_bib0500","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2017.04.028","article-title":"Plaque angiogenesis and intraplaque hemorrhage in atherosclerosis","volume":"816","author":"Parma","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104664_bib0505","article-title":"Haptoglobin genotype-dependent anti-inflammatory signaling in CD163(+) macrophages","volume":"2013","author":"Landis","year":"2013","journal-title":"Int. J. Inflam."},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0510","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.0000109414.78907.F9","article-title":"Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery","volume":"94","author":"Philippidis","year":"2004","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.phrs.2020.104664_bib0515","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCRESAHA.113.301656","article-title":"Liver X receptor activation stimulates iron export in human alternative macrophages","volume":"113","author":"Bories","year":"2013","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0520","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2011.02.001","article-title":"Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages","volume":"508","author":"Harada","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0525","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1172\/JCI93025","article-title":"CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis","volume":"128","author":"Guo","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0530","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1172\/JCI120123","article-title":"Alternative macrophages in atherosclerosis: not always protective!","volume":"128","author":"Pourcet","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0535","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2249.2005.02934.x","article-title":"Macrophage activation switching: an asset for the resolution of inflammation","volume":"142","author":"Porcheray","year":"2005","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0540","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1681\/ASN.2009060615","article-title":"Distinct macrophage phenotypes contribute to kidney injury and repair","volume":"22","author":"Lee","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"17","key":"10.1016\/j.phrs.2020.104664_bib0545","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.1016086108","article-title":"HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells","volume":"108","author":"Feig","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2020.104664_bib0550","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fphar.2014.00195","article-title":"The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis","volume":"5","author":"Habib","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0555","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.imbio.2014.09.011","article-title":"Macrophage iron homeostasis and polarization in the context of cancer","volume":"220","author":"Jung","year":"2015","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/j.phrs.2020.104664_bib0560","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2012.03.003","article-title":"Iron levels in polarized macrophages: regulation of immunity and autoimmunity","volume":"11","author":"Recalcati","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0565","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1182\/blood-2011-02-337212","article-title":"Low hepcidin accounts for the proinflammatory status associated with iron deficiency","volume":"118","author":"Pagani","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0570","doi-asserted-by":"crossref","first-page":"e0196921","DOI":"10.1371\/journal.pone.0196921","article-title":"Cell iron status influences macrophage polarization","volume":"13","author":"Agoro","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0575","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI44490","article-title":"An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice","volume":"121","author":"Sindrilaru","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0580","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/ALN.0000000000001653","article-title":"Iron loading exaggerates the inflammatory response to the toll-like receptor 4 ligand lipopolysaccharide by altering mitochondrial homeostasis","volume":"127","author":"Hoeft","year":"2017","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0585","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.neuron.2014.07.027","article-title":"TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord","volume":"83","author":"Kroner","year":"2014","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.phrs.2020.104664_bib0590","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0595","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/ATVBAHA.118.312215","article-title":"Hepcidin deficiency protects against atherosclerosis","volume":"39","author":"Malhotra","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104664_bib0600","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1002\/cam4.1670","article-title":"Iron overloaded polarizes macrophage to proinflammation phenotype through ROS\/acetyl-p53 pathway","volume":"7","author":"Zhou","year":"2018","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.phrs.2020.104664_bib0605","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/CIRCRESAHA.107.151704","article-title":"Low density lipoprotein undergoes oxidation within lysosomes in cells","volume":"100","author":"Wen","year":"2007","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.phrs.2020.104664_bib0610","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood-2011-01-330324","article-title":"Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0615","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3324\/haematol.2018.197517","article-title":"Macrophage ferroportin is essential for stromal cell proliferation in wound healing","volume":"104","author":"Recalcati","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0620","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.181.4.2723","article-title":"Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation","volume":"181","author":"Wang","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0625","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cmet.2012.10.001","article-title":"mTOR regulates cellular iron homeostasis through tristetraprolin","volume":"16","author":"Bayeva","year":"2012","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0630","doi-asserted-by":"crossref","DOI":"10.3390\/ph12020094","article-title":"Ironing out macrophage immunometabolism","volume":"12","author":"Recalcati","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6\u20137","key":"10.1016\/j.phrs.2020.104664_bib0635","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbagrm.2013.02.003","article-title":"Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action","volume":"1829","author":"Brooks","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117098","article-title":"Inhibition of bone morphogenetic protein signal transduction prevents the medial vascular calcification associated with matrix Gla protein deficiency","volume":"10","author":"Malhotra","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0645","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/ATVBAHA.111.242594","article-title":"Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis","volume":"32","author":"Derwall","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0650","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/ATVBAHA.111.240101","article-title":"Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis","volume":"32","author":"Saeed","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0655","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCRESAHA.110.219071","article-title":"Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification","volume":"107","author":"Yao","year":"2010","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0660","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1681\/ASN.2016060651","article-title":"Vitamin K-dependent carboxylation of matrix gla protein influences the risk of calciphylaxis","volume":"28","author":"Nigwekar","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0665","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000484418","article-title":"Increased bone morphogenetic protein signaling in the cutaneous vasculature of patients with calciphylaxis","volume":"46","author":"Nigwekar","year":"2017","journal-title":"Am. J. Nephrol."},{"issue":"12","key":"10.1016\/j.phrs.2020.104664_bib0670","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/ATVBAHA.112.300471","article-title":"Myeloid Kruppel-like factor 4 deficiency augments atherogenesis in ApoE-\/- mice--brief report","volume":"32","author":"Sharma","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0675","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gendis.2014.07.005","article-title":"Bone Morphogenetic Protein (BMP) signaling in development and human diseases","volume":"1","author":"Wang","year":"2014","journal-title":"Genes Dis."},{"issue":"9","key":"10.1016\/j.phrs.2020.104664_bib0680","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/ATVBAHA.116.306874","article-title":"Do the Apoe-\/- and Ldlr-\/- Mice Yield the Same Insight on Atherogenesis?","volume":"36","author":"Getz","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104664_bib0685","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/ATVBAHA.111.222745","article-title":"Apolipoprotein E induces antiinflammatory phenotype in macrophages","volume":"31","author":"Baitsch","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0690","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cmet.2014.07.007","article-title":"Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload","volume":"20","author":"Altamura","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2020.104664_bib0695","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ebiom.2019.08.014","article-title":"New insights into the role of iron in inflammation and atherosclerosis","volume":"47","author":"Cornelissen","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.phrs.2020.104664_bib0700","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2169\/internalmedicine.48.1578","article-title":"Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis","volume":"48","author":"Demirag","year":"2009","journal-title":"Intern. Med."},{"issue":"19","key":"10.1016\/j.phrs.2020.104664_bib0705","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral Iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and Iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2020.104664_bib0710","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/bs.vh.2019.01.012","article-title":"Hepcidin in chronic kidney disease anemia","volume":"110","author":"Santos-Silva","year":"2019","journal-title":"Vitam. Horm."},{"issue":"3","key":"10.1016\/j.phrs.2020.104664_bib0715","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejim.2011.01.011","article-title":"Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome","volume":"22","author":"Zimmermann","year":"2011","journal-title":"Eur. J. Intern. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0720","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/met.2010.0121","article-title":"Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"9","author":"Senates","year":"2011","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"10","key":"10.1016\/j.phrs.2020.104664_bib0725","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3899\/jrheum.110339","article-title":"Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis","volume":"38","author":"Abdel-Khalek","year":"2011","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104664_bib0730","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.numecd.2010.01.003","article-title":"Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease","volume":"21","author":"Valenti","year":"2011","journal-title":"Nutrition, metabolism, and cardiovascular diseases: NMCD"},{"issue":"8","key":"10.1016\/j.phrs.2020.104664_bib0735","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/ndt\/gfq760","article-title":"Hepcidin as well as TNF-alpha are significant predictors of arterial stiffness in patients on maintenance hemodialysis","volume":"26","author":"Kuragano","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"12","key":"10.1016\/j.phrs.2020.104664_bib0740","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfs488","article-title":"Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients","volume":"28","author":"van der Weerd","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0745","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/ATVBAHA.113.302381","article-title":"Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population","volume":"34","author":"Galesloot","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"62","key":"10.1016\/j.phrs.2020.104664_bib0750","article-title":"Antiinflammatory therapy in clinical care: the CANTOS trial and beyond","volume":"5","author":"Aday","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"issue":"9670","key":"10.1016\/j.phrs.2020.104664_bib0755","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","volume":"373","author":"Ridker","year":"2009","journal-title":"Lancet"},{"issue":"160","key":"10.1016\/j.phrs.2020.104664_bib0760","article-title":"Pharmacological targeting of the hepcidin\/ferroportin axis","volume":"7","author":"Sebastiani","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104664_bib0765","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.ATV.16.8.1000","article-title":"Interleukin-1 beta in coronary arteries of patients with ischemic heart disease","volume":"16","author":"Galea","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104664_bib0770","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/17584299.2017.1319787","article-title":"Interleukin-6 in atherosclerosis: atherogenic or atheroprotective?","volume":"12","author":"Reiss","year":"2017","journal-title":"Clin. Lipidol."},{"issue":"9822","key":"10.1016\/j.phrs.2020.104664_bib0775","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"issue":"9822","key":"10.1016\/j.phrs.2020.104664_bib0780","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.phrs.2020.104664_bib0785","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"issue":"30","key":"10.1016\/j.phrs.2020.104664_bib0790","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur. Heart J."},{"issue":"19","key":"10.1016\/j.phrs.2020.104664_bib0795","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/heartjnl-2016-310875","article-title":"Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction","volume":"103","author":"Holte","year":"2017","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.phrs.2020.104664_bib0800","doi-asserted-by":"crossref","first-page":"0050078","DOI":"10.1371\/journal.pmed.0050078","article-title":"Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review","volume":"5","author":"Danesh","year":"2008","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.phrs.2020.104664_bib0805","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.phrs.2020.104664_bib0810","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819321152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819321152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:41:31Z","timestamp":1778794891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819321152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":162,"alternative-id":["S1043661819321152"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104664","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hepcidin and iron homeostasis in atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104664"}}